Mir-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Patron, Juan P ^a   Fendler, Annika ^b,c,d   Bild, Matthias ^a   Jung, Ulrike ^a   Müller, Henrik ^a   Arntzen, Magnus Ø ^e,f,g   Piso, Chloe ^a   Stephan, Carsten ^b   Thiede, Bernd ^e   Mollenkopf, Hans Joachim ^a   Jung, Klaus ^c   Kaufmann, Stefan H E ^a   Schreiber, Jörg ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Institute for Urologic Research   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e UNIVERSITY OF OSLO   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR; FAS ANTIGEN; FAS APOPTOSIS INHIBITORY MOLECULE; GLUTATHIONE TRANSFERASE P1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; FAIM PROTEIN, HUMAN; GLUTATHIONE TRANSFERASE; MICRORNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER PATIENT; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; MALE; METABOLIC ACTIVATION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; SENSITIZATION; ADENOCARCINOMA; DRUG EFFECT; GENETICS; HELA CELL; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE;

ADENOCARCINOMA; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; RECEPTORS, DEATH DOMAIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859983890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035345     Document Type: Article

References (54)

1. Kerr JF, Wyllie AH, Currie AR, (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257.
2. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11.
3. Aggarwal BB, (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756.
4. Fischer U, Janicke RU, Schulze-Osthoff K, (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
5. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Pillai RS, Bhattacharyya SN, Filipowicz W, (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118-126.
7. Garofalo M, Condorelli GL, Croce CM, Condorelli G, (2010) MicroRNAs as regulators of death receptors signaling. Cell Death Differ. 17: 200-208.
8. McCarthy JJ, (2008) MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta 1779: 682-691.
9. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, et al. (2007) Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2: e873.
10. Walden TB, Timmons JA, Keller P, Nedergaard J, Cannon B, (2009) Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. J Cell Physiol 218: 444-449.
11. Song G, Zhang Y, Wang L, (2009) MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 284: 31921-31927.
12. Haas JD, Nistala K, Petermann F, Saran N, Chennupati V, et al. (2011) Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in alphabeta and gammadelta T cells. PloS one 6: e20171.
13. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, et al. (2007) MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358: 12-17.
14. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
15. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J, (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105.
16. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29.
17. Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, et al. (2009) MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochemical and biophysical research communications 388: 483-489.
18. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, et al. (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352.
19. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, et al. (2010) miR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814.
20. Nohata N, Hanazawa T, Enokida H, Seki N, (2012) microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers. Oncotarget 3: 9-21.
21. Hu G, Chen D, Li X, Yang K, Wang H, et al. (2010) miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 10: 190-197.
22. Qin W, Dong P, Ma C, Mitchelson K, Deng T, et al. (2011) MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene.
23. Beg AA, Baltimore D, (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784.
24. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C, (2006) Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25: 6800-6816.
25. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG, (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985.
26. Meister G, Landthaler M, Dorsett Y, Tuschl T, (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550.
27. Hutvagner G, Simard MJ, Mello CC, Zamore PD, (2004) Sequence-specific inhibition of small RNA function. PLoS Biol 2: E98.
28. Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, et al. (1998) Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 58: 1741-1749.
29. Patel VA, Longacre A, Hsiao K, Fan H, Meng F, et al. (2006) Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity. J Biol Chem 281: 4663-4670.
30. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
31. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-110.
32. Schneider TJ, Fischer GM, Donohoe TJ, Colarusso TP, Rothstein TL, (1999) A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J Exp Med 189: 949-956.
33. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
34. Townsend DM, Tew KD, (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22: 7369-7375.
35. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
36. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
37. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
38. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, et al. (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PloS one 4: e8003.
39. Rodriguez-Berriguete G, Fraile B, Paniagua R, Aller P, Royuela M, (2012) Expression of NF-kappaB-related proteins and their modulation during TNF-alpha-provoked apoptosis in prostate cancer cells. The Prostate 72: 40-50.
40. Segura MF, Sole C, Pascual M, Moubarak RS, Perez-Garcia MJ, et al. (2007) The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis. J Neurosci 27: 11228-11241.
41. Sole C, Dolcet X, Segura MF, Gutierrez H, Diaz-Meco MT, et al. (2004) The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling. J Cell Biol 167: 479-492.
42. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, et al. (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317: 1220-1224.
43. Huo J, Xu S, Guo K, Zeng Q, Lam KP, (2009) Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes. Cell Death Differ 16: 1062-1070.
44. Wu Y, Fan Y, Xue B, Luo L, Shen J, et al. (2006) Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25: 5787-5800.
45. Mutallip M, Nohata N, Hanazawa T, Kikkawa N, Horiguchi S, et al. (2011) Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med 27: 345-352.
46. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, et al. (2011) The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. British journal of cancer 104: 808-818.
47. Kojima S, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, et al. (2012) Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. British journal of cancer 106: 405-413.
48. Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, et al. (2011) MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic acids research.
49. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
50. Garzon R, Calin GA, Croce CM, (2009) MicroRNAs in Cancer. Annual review of medicine 60: 167-179.
51. Witten D, Tibshirani R, Gu SG, Fire A, Lui WO, (2010) Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC biology 8: 58.
52. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PloS one 3: e2557.
53. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, et al. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176.
54. Cox J, Mann M, (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372.